PTGS2 and non-small cell lung carcinoma: In NSCLC, cyclo-oxygenase 2 (COX-2) gene is over-expressed in nearly all stages of disease progression [16] and downstream enzymes of the COX-2 pathway involved in prostanoid synthesis such as prostaglandin E2 synthase is also up-regulated [17].